Monday, October 1, 2012

Discovery through Commercialization - 7th Annual Conference - Hyderabad, India

News &
& TrainingsSpeaking & PublishingNetworking & CommunitiesExhibiting AdvertisingCareer Center
Discovery through Commercialization
The 7th Annual Conference will include multiple tracks focusing upon the confluence of discovery,  development, manufacturing and commercialization towards the development of innovative, path-breaking strategies in the realm of personalised health care.
Here are a few of the sessions at this year's conference.
Target Discovery
This session chaired by V. N. Balaji, Consultant, Discovery Research will discuss
  • Applications of Next Generation Sequencing and Genomics—from Target Discovery to Clinical Trials and Beyond by Raja Mugasimangalam, CEO, Genotypic Technology
  • Distilling Omics Data for Drug Discovery by Kalpana Krishnaswamy, CEO, Metaome Science Informatics
  • Homology Modeling of Proteins and Ligand Docking: How close are we to drug discovery?
    by R. Sowdhamini, Associate Professor, National Centre for Biological Sciences Processes
Public Knowledge and Perceptions as Drivers or Barriers to the
Future of Clinical Research in India
This session chaired by Tal Burt, Scientific Director, Duke Global Proof-of-Concept (POC), Research Network will discuss
  • PARTAKE Program and Survey of Public Knowledge and Perceptions of Clinical Research
    by Tal Burt, Scientific Director, Duke Global Proof-of-Concept (POC) Research Network
  • Challenges of Drug Development in India – The Relevance of Public Awareness
    and Partnership
    by Krathish Bopanna, President and CEO, Semler Research
  • The Role of Stakeholder Collaborations in the Ethical Conduct of Clinical Research
    by Nandini Kumar, Former Deputy Director General, Senior Grade Investigator NIH project, National Institute of Epidemiology
Health Economics and Valuation
This session chaired by Shashidhar Rao, Head Global Medical Affairs and HEOR, India Operations, Novartis Healthcare will discuss
  • New Molecules: Paths to their Development and Commercialization in India by Nidhi Saxena, Founder and CEO, Karmic Lifesciences
  • Personalization and Regulatory Framework by Arun Bhatt, President, Clininvent Research
  • Approach to Early Phase Health Economics Evaluations by Adrian McKemey, Practice Leader, Product Development & Commercialization, Quintiles
7th Annual Conference Registration Fees Reduced
Registration fees at the 7th Annual Conference have been reduced by nearly 20% to as low as Rs. 9,000 + taxes to help the industry participate in large numbers and gain immensely through this unique networking opportunity. Click here to view the conference program with over 75 International & India industry leaders.
For more information and group registrations please contact or call +91.98.2058.7798.
Follow us and tweet on the 7th Annual Conference with #DIAIndiaAM2012
Email Preferences    |    My DIA    |    Forward to a Friend    |    FacebookLinkedInTwitterYouTube

No comments:

Post a Comment